Pediatrics CME Courses

This activity is intended for pediatric oncology nurses, pediatric nurses, oncology nurses, nurse practitioners, nurse managers, infusion nurses, research nurses, physician assistants, and other health care providers who care for or have an interest in pediatric patients with high-risk neuroblastoma

By the end of the session the participant will be able to:

• Describe the underlying pathophysiological and typical clinical features of pediatric GHD as they pertain to therapeutic targets
• Describe the optimal approach in diagnosing pediatric GHD and apply it to a patient case
• Given a patient with pediatric GHD, design a pharmacotherapeutic regimen based on his or her clinical presentation
• Evaluate patient cases during follow-up visits, including during transition therapy to adulthood when relevant, in a manner that optimizes one or more of the following: efficacy, safety, quality of life, or patient education and adherence
• Describe best practices in tracking response to pediatric GHD therapy